Navigation Links
Genesis Biopharma's Scientific and Medical Advisory Board Welcomes Dr. Steven A. Rosenberg, Chief of the Surgery Branch at the NCI
Date:11/17/2011

LOS ANGELES, Nov. 17, 2011 /PRNewswire/ -- Genesis Biopharma, Inc. (OTCBB: GNBP), a biotechnology company developing targeted cancer immunotherapies, today announced that Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch at the National Cancer Institute, has joined the Company's Scientific and Medical Advisory Board.  Dr. Rosenberg also is Professor of Surgery at the Uniformed Services University of Health Sciences and at the George Washington University School of Medicine and Health Sciences, both in Washington D.C.  

"We are honored to have Dr. Rosenberg serve on our Scientific and Medical Advisory Board.  A leading authority on immunology and cancer, Dr. Rosenberg pioneered adoptive cell therapy using autologous tumor infiltrating lymphocytes (TILs) to successfully treat patients with metastatic melanoma," stated Anthony J. Cataldo, Chairman and Chief Executive Oficer of Genesis Biopharma.  Genesis Biopharma recently licensed rights to certain intellectual property relating to the use of adoptive cell therapy using autologous TILs for the treatment of metastatic melanoma, ovarian, breast and colorectal cancers from the National Institutes of Health.  "As the inventor of this therapy, Dr. Rosenberg will be an invaluable asset to Genesis Biopharma as we advance the clinical development for Contego™, our ready-to-infuse adoptive cell therapy using TILs, to treat Stage IV metastatic melanoma," added Mr. Cataldo.

Dr. Rosenberg has pioneered the development of immunotherapy that has resulted in the first effective immunotherapies for selected patients with advanced cancer. He has also pioneered the development of gene therapy, and was first to successfully insert foreign genes into humans and to conduct clinical studies of the gene therapy of cancer.

Dr. Rosenberg's work in tumor immunology was recently highlighted in the July issue of Oncology Times in an article titled, "'/>"/>

SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Triple Analysis: Prostate Cancer, Angiogenesis and Peptides
2. ThermoGenesis Corp. to Announce First Quarter Fiscal 2012 Results on November 10, 2011
3. Genesis Biopharma Signs Worldwide License Agreement with the NIH for Adoptive Cell Therapy to Treat a Variety of Cancers
4. Efficacy Data from Phase III VELOUR Trial in Colorectal Cancer to be Presented at Angiogenesis Foundations 2011 M. Judah Folkman International Conference in Cambridge, Mass.
5. Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise
6. ThermoGenesis Reports Fourth Quarter and Year End 2011 Results; Annual Net Loss Reduced by More Than 50 Percent
7. ThermoGenesis Presentation at Rodman & Renshaw Conference
8. Genesis Biopharma Announces Letter to Shareholders Posted to Website
9. ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao
10. Mummy News: Genesis Medical Imaging Mobile CT Scan Unit Helps Chicagos Field Museum Discover Ancient Secrets
11. Genesis Biopharma to Hold Business Update Conference Call on June 29
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  Cardinal Health today ... acquire Johnson & Johnson,s Cordis business for $1.944 billion ... after consultations with relevant works councils and trade unions. ... the United States and key non-U.S. countries ... and other customary closing conditions. Headquartered in ...
(Date:5/28/2015)...  According to Kalorama Information, CVS Health Corporation,s agreement ... billion fits a prevailing trend in the healthcare industry ... The U.S. long term care industry has experienced steady ... aging population increases demand for all forms of long ... report, The Long Term Care Market: Nursing Homes, ...
(Date:5/28/2015)... 2015  Eli Lilly and Company (NYSE: LLY ) ... offer for up to $1.6 billion aggregate principal amount (the ... $1.45 billion in aggregate principal amount of the notes listed ... withdrawn on or prior to 5:00 p.m., New ... early tender date for the offer. The ...
Breaking Medicine Technology:Cardinal Health Binding Offer To Acquire Cordis Accepted 2Cardinal Health Binding Offer To Acquire Cordis Accepted 3Cardinal Health Binding Offer To Acquire Cordis Accepted 4Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 2Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 3Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 4Lilly Announces the Early Results of Its Cash Tender Offer 2Lilly Announces the Early Results of Its Cash Tender Offer 3Lilly Announces the Early Results of Its Cash Tender Offer 4Lilly Announces the Early Results of Its Cash Tender Offer 5
(Date:5/28/2015)... May 28, 2015 Cancer survivors who ... improvements in physical activity, fitness and quality of life, ... Yale Cancer Center and Jennifer Ligibel, MD, senior physician ... Dana Farber Cancer Institute. The findings will be presented ... (ASCO) Annual Meeting in Chicago. , ...
(Date:5/28/2015)... May 28, 2015 Ask not what your ... things you can do with your racquet. With the launch ... Stefan Bojic, who brings his astonishing tricks and unique skill ... a series of videos, the trick artist playfully demonstrates how ... skills in a fun way, but also challenges tennis enthusiasts ...
(Date:5/28/2015)... TX (PRWEB) May 28, 2015 ... provides comprehensive information on the therapeutic development for ... muscle contractions causing abnormal, often repetitive, movements, postures, ... of all ages and backgrounds. The report strengthens ... to produce first-in-class and best-in-class products. Complete report ...
(Date:5/28/2015)... Orem, UT—Dymicron, Inc., (dymicron.com) confirmed the successful ... Triadyme-C cervical total disc replacement device. The two surgeries ... at the American Institute of Minimally Invasive Surgery (AIMIS) ... to the implantation of the Dymicron devices,” said Dr. ... Chief of Neurosurgery for the University Medical Center, Las ...
(Date:5/28/2015)... SpendWell Health, an e-commerce marketplace for health care ... “Cool Vendor” by Gartner in the April 24, 2015 ... by Jeff Cribbs, Constance Sjoquist, Robert H. Booz, ... and services in health care technology—which serve as leading ... market. , SpendWell’s solution delivers the next generation ...
Breaking Medicine News(10 mins):Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 2Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 3Health News:LIVESTRONG at the YMCA Program Shows Significant Gains for Cancer Survivor Participants 4Health News:Tennis Artist Baffles Novak Djokovic - HEAD Launches Trick Shot Campaign “Frame & Play” 2Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Dystonia Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Dymicron, Inc., Announces the First Human Implantation of their Triadyme-CTM Cervical Total Disc Replacement Device in Cyprus 2Health News:SpendWell Named a “Cool Vendor” by Gartner 2Health News:SpendWell Named a “Cool Vendor” by Gartner 3Health News:SpendWell Named a “Cool Vendor” by Gartner 4
... Tall toddlers and rapidly growing teens are likely to ... in later life, suggests// research in the Journal of ... pounds after the age of 15 boosted cholesterol levels, ... just under 3000 participants of a Medical Research Council ...
... help prevent obesity among children than they do to cause ... measure of obesity// rose more than twice as fast when ... they were in school. ,And obese children were ... faster than other children did during the school year. It ...
... Buyers beware. Businesses that encourage employees to order prescription ... financial rewards they think they are//. ,In ... have become popular among cost-conscious companies offering prescription benefits ... 2005 Federal Trade Commission (FTC) report – is that, ...
... Company Sanofi-Aventis has come out with a cheap and ... in association with the Drugs// for Neglected Diseases initiative ... Sans Frontieres (MSF). This treatment called as ASAQ is ... earlier treatment for malaria had two tablets which had ...
... is in the news again. His company will be given 670,000 ... culled last month, in the wake of a bird flu outbreak, ... which has a 4800 strong workforce, had reported sales as low ... the compensation, though there are talks that the EU may foot ...
... March heralds spring in several parts of the ... tropical hinterlands//. But March is infamous for a strange 'fever', ... homes, especially those of school- and college–going children. Yes, it ... when adolescent competence, along with parental ...
Cached Medicine News:Health News:Schools Help Hold the Line Against Childhood Obesity 2Health News:Schools Help Hold the Line Against Childhood Obesity 3Health News:Mail-Order Drugs: Deal or No Deal? 2Health News:Turkey Giant to Receive King-sized Compensation 2Health News:Busting the Exam Blues 2Health News:Busting the Exam Blues 3Health News:Busting the Exam Blues 4
... system includes a cruciate sparing version ... mates with both resurfacing and inset ... repeatable kinematics and fit with tibial ... wear. Constant cutting guide peg locations ...
... The TC-PLUS solution tricompartmental total knee ... with knee arthroplasty. State-of-the-art design and manufacturing ... achieve optimum biomechanical function as well as ... polyethylene tibial insert to keep wear to ...
The Foundation PS knee offers a femoral option and tibial insert which provides a specially designed cam action that engages at 60 degrees of flexion to induce a smooth stable femoral roll-back motio...
... Natural Knee design includes several ... CSTi porous coating option for ... a unique bone preserving posterior ... groove to maximize range of ...
Medicine Products: